Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD
- PMID: 23341865
- PMCID: PMC3541601
- DOI: 10.1371/journal.pone.0051734
Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD
Abstract
Background: To evaluate the risk of foetal loss associated with pandemic influenza vaccination in pregnancy. Retrospective cohort study. UK General Practice Research Database Pregnancies ending in delivery or spontaneous foetal death after 21 October 2009 and starting before 01 January 2010.
Methodology/principal findings: Hazard ratios of foetal death for vaccinated compared to unvaccinated pregnancies were estimated for gestational weeks 9 to 12, 13 to 24 and 25 to 43 using discrete-time survival analysis. Separate models were specified to evaluate whether the potential effect of vaccination on foetal loss might be transient (for ~4 weeks post vaccination only) or more permanent (for the duration of the pregnancy). 39,863 pregnancies meeting our inclusion criteria contributed a total of 969,322 gestational weeks during the study period. 9,445 of the women were vaccinated before or during pregnancy. When the potential effect of vaccination was assumed to be transient, the hazard of foetal death during gestational weeks 9 through 12 (HR(unadj) 0.56; CI(95) 0.43 to 0.73) and 13 through 24 (HR(unadj) 0.45; CI(95) 0.28 to 0.73) was lower in the 4 weeks after vaccination than in other weeks. Where the more permanent exposure definition was specified, vaccinated pregnancies also had a lower hazard of foetal loss than unvaccinated pregnancies in gestational weeks 9 through 12 (HR(unadj) 0.74; CI(95) 0.62 to 0.88) and 13 through 24 (HR(unadj) 0.59; CI(95) 0.45 to 0.77). There was no difference in the hazard of foetal loss during weeks 25 to 43 in either model. Sensitivity analyses suggest the strong protective associations observed may be due in part to unmeasured confounding.
Conclusions/significance: Influenza vaccination during pregnancy does not appear to increase the risk of foetal death. This study therefore supports the continued recommendation of influenza vaccination of pregnant women.
Conflict of interest statement
Figures
Similar articles
-
Risk of fetal death after pandemic influenza virus infection or vaccination.N Engl J Med. 2013 Jan 24;368(4):333-40. doi: 10.1056/NEJMoa1207210. Epub 2013 Jan 16. N Engl J Med. 2013. PMID: 23323868 Free PMC article.
-
Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.Hum Vaccin Immunother. 2013 Apr;9(4):917-23. doi: 10.4161/hv.23277. Epub 2013 Jan 30. Hum Vaccin Immunother. 2013. PMID: 23364304 Free PMC article.
-
Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.BMJ. 2012 May 2;344:e2794. doi: 10.1136/bmj.e2794. BMJ. 2012. PMID: 22551713 Free PMC article.
-
A systematic review and meta-analysis of fetal outcomes following the administration of influenza A/H1N1 vaccination during pregnancy.Int J Gynaecol Obstet. 2018 May;141(2):141-150. doi: 10.1002/ijgo.12394. Epub 2017 Dec 18. Int J Gynaecol Obstet. 2018. PMID: 29149524 Review.
-
Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes.Vaccine. 2015 Apr 27;33(18):2108-17. doi: 10.1016/j.vaccine.2015.02.068. Epub 2015 Mar 8. Vaccine. 2015. PMID: 25758932 Review.
Cited by
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.MMWR Recomm Rep. 2024 Aug 29;73(5):1-25. doi: 10.15585/mmwr.rr7305a1. MMWR Recomm Rep. 2024. PMID: 39197095 Free PMC article.
-
Safety of influenza vaccination during pregnancy: a systematic review.BMJ Open. 2023 Sep 6;13(9):e066182. doi: 10.1136/bmjopen-2022-066182. BMJ Open. 2023. PMID: 37673449 Free PMC article.
-
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis.Vaccine. 2023 Jun 7;41(25):3688-3700. doi: 10.1016/j.vaccine.2023.03.038. Epub 2023 Mar 27. Vaccine. 2023. PMID: 37012114 Free PMC article. Review.
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1. MMWR Recomm Rep. 2022. PMID: 36006864 Free PMC article.
-
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.Vaccine. 2021 Sep 24;39(40):5891-5908. doi: 10.1016/j.vaccine.2021.08.034. Epub 2021 Aug 13. Vaccine. 2021. PMID: 34489131 Free PMC article. Review.
References
-
- Skowronski DM, De SG (2009) Is routine influenza immunization warranted in early pregnancy? Vaccine 27: 4754–4770. - PubMed
-
- Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D (2008) Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 8: 44–52. - PubMed
-
- Stanwell-Smith R, Parker AM, Chakraverty P, Soltanpoor N, Simpson CN (1994) Possible association of influenza A with fetal loss: investigation of a cluster of spontaneous abortions and stillbirths. Commun Dis Rep CDR Rev 4: R28–32. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical